WallStreetZenWallStreetZen

NASDAQ: SPTX
Seaport Therapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for SPTX

Based on 8 analysts offering 12 month price targets for Seaport Therapeutics Inc

Min Forecast
$28.00+42.86%
Avg Forecast
$37.25+90.05%
Max Forecast
$50.00+155.1%

Should I buy or sell SPTX stock?

Based on 8 analysts offering ratings for Seaport Therapeutics Inc.

Strong Buy
Strong Buy
6 analysts 75%
Buy
2 analysts 25%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although SPTX's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates SPTX as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +5.11% per year. Learn More

Be the first to know when Wall Street analysts revise their SPTX stock forecasts and price targets.

SPTX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-10-14
lockedlocked$00.00+00.00%2026-10-08
lockedlocked$00.00+00.00%2026-09-25
lockedlocked$00.00+00.00%2026-08-26
lockedlocked$00.00+00.00%2026-05-26
Leerink Partners
Top 9%
92
BuyInitiates Coverage On$35.00+78.57%2026-05-26
JP Morgan
Top 17%
84
Strong BuyInitiates Coverage On$42.00+114.29%2026-05-26
Stifel Nicolaus
Bottom 13%
13
Strong BuyInitiates Coverage On$30.00+53.06%2026-05-26

1 of 1

Forecast return on equity

Is SPTX forecast to generate an efficient return?

Company
N/A
Industry
21.29%
Market
171.95%

Forecast return on assets

Is SPTX forecast to generate an efficient return on assets?

Company
N/A
Industry
21.83%

SPTX earnings per share forecast

What is SPTX's earnings per share in the next 3 years based on estimates from 12 analysts?

Avg 1 year Forecast
-$6.24
Avg 2 year Forecast
-$2.60
Avg 3 year Forecast
-$2.66

SPTX revenue forecast

What is SPTX's revenue in the next 3 years based on estimates from 11 analysts?

Avg 1 year Forecast
$0.0
Avg 2 year Forecast
$0.0
Avg 3 year Forecast
$0.0

SPTX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
SPTX$19.60$37.25+90.05%Strong Buy
INBX$71.78$245.00+241.32%Buy
JANX$17.47$33.20+90.04%Strong Buy
SGP$32.24$38.00+17.87%Buy
MLTX$11.78$34.75+194.99%Strong Buy
View Top Biotech Stocks

Seaport Therapeutics Stock Forecast FAQ

Is Seaport Therapeutics Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 8 Wall Street analysts covering (NASDAQ: SPTX) stock is to Strong Buy SPTX stock.

Out of 8 analysts, 6 (75%) are recommending SPTX as a Strong Buy, 2 (25%) are recommending SPTX as a Buy, 0 (0%) are recommending SPTX as a Hold, 0 (0%) are recommending SPTX as a Sell, and 0 (0%) are recommending SPTX as a Strong Sell.

If you're new to stock investing, here's how to buy Seaport Therapeutics stock.

What is SPTX's earnings growth forecast for 2026-2028?

(NASDAQ: SPTX) Seaport Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 11.65%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 32.44%.

Seaport Therapeutics's earnings in 2026 is N/A.On average, 12 Wall Street analysts forecast SPTX's earnings for 2026 to be -$334,062,750, with the lowest SPTX earnings forecast at -$697,717,189, and the highest SPTX earnings forecast at -$211,338,611. On average, 12 Wall Street analysts forecast SPTX's earnings for 2027 to be -$138,927,836, with the lowest SPTX earnings forecast at -$172,593,199, and the highest SPTX earnings forecast at -$111,514,842.

In 2028, SPTX is forecast to generate -$142,145,022 in earnings, with the lowest earnings forecast at -$194,626,374 and the highest earnings forecast at -$112,414,155.

What is SPTX's revenue growth forecast for 2026-2028?

(NASDAQ: SPTX) Seaport Therapeutics's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 29.74%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 12.61%.

Seaport Therapeutics's revenue in 2026 is N/A.On average, 11 Wall Street analysts forecast SPTX's revenue for 2026 to be $0, with the lowest SPTX revenue forecast at $0, and the highest SPTX revenue forecast at $0. On average, 11 Wall Street analysts forecast SPTX's revenue for 2027 to be $0, with the lowest SPTX revenue forecast at $0, and the highest SPTX revenue forecast at $0.

In 2028, SPTX is forecast to generate $0 in revenue, with the lowest revenue forecast at $0 and the highest revenue forecast at $0.

What is SPTX's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: SPTX) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 21.83%.

What is SPTX's Price Target?

According to 8 Wall Street analysts that have issued a 1 year SPTX price target, the average SPTX price target is $37.25, with the highest SPTX stock price forecast at $50.00 and the lowest SPTX stock price forecast at $28.00.

On average, Wall Street analysts predict that Seaport Therapeutics's share price could reach $37.25 by Oct 14, 2027. The average Seaport Therapeutics stock price prediction forecasts a potential upside of 90.05% from the current SPTX share price of $19.60.

What is SPTX's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: SPTX) Seaport Therapeutics's current Earnings Per Share (EPS) is N/A. On average, analysts forecast that SPTX's EPS will be -$6.24 for 2026, with the lowest EPS forecast at -$13.03, and the highest EPS forecast at -$3.95. On average, analysts forecast that SPTX's EPS will be -$2.60 for 2027, with the lowest EPS forecast at -$3.22, and the highest EPS forecast at -$2.08. In 2028, SPTX's EPS is forecast to hit -$2.66 (min: -$3.64, max: -$2.10).

What is SPTX's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: SPTX) forecast ROE is N/A, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.